학술논문
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.
Document Type
Article
Author
Source
Clinical Lymphoma, Myeloma & Leukemia; Nov2022, Vol. 22 Issue 11, p812-824, 13p
Subject
Language
ISSN
21522650